ClinicalTrials.gg
CompletedNCT07143500Updated Aug 27, 2025

Comparative Study of Action Observation Training Versus Task Oriented Training on Reaching in Patients With Stroke

An interventional study of Selected physical therapy program and Task Oriented Training for Upper limb in Stroke, sponsored by Ahmed Alshimy. Completed at 1 site in Egypt. Open to male participants aged 50 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-08-27.

Sponsored by Ahmed Alshimy · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
39
Allocation
Randomized
Ages
50 Years to 65 Years
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 93 studies in Stroke with a site in Egypt — 25 open to participants now, 29 under way, 2 of them phase 3. Stroke · Egypt.

Enrollment
61st of 75
39 · median 42
Started
2025
with 21 others
No phase
66 of 93
18 open now
Registered
71st of 93
by date
Lead sponsor
4 of 93
Ahmed Alshimy

Among the 93 studies in Stroke with a site in Egypt, this one is the 61st largest by enrollment of the 75 interventional ones that give a count, is one of 22 that started in 2025, is one of 66 with no phase, and was the 71st registered.

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's enrollment of 39 is below the median of 49 across 6,024 interventional studies indexed under Stroke.

Browse Stroke studies →

Open to participants now

25 of the 93 studies in Stroke with a site in Egypt are open now, in 1 country. Each count lists the studies.

All 25 open studies →

Who these studies take

Of the 1,415 Stroke studies recruiting now, 697 (49%) set no upper age limit and 280 (20%) stop at 75 or younger; 77 take children under 18; 196 take healthy volunteers.

This study: 50 Years to 65 Years · male · no healthy volunteers.

The full table on the hub →
Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 93 studies in Stroke with a site in Egypt, or all of them as a file.
02

Study summary

Stroke is characterized by a sudden onset of localized or generalized brain dysfunction, with symptoms persisting for at least 24 hours or resulting in death. In the chronic phase following a stroke, hand dysfunction is commonly observed, often characterized by reduced finger strength and abnormal hand flexion patterns. Reaching is a crucial aspect of daily tasks, including activities like drinking, interacting with a touch screen, or pressing elevator buttons.

Read the detailed description

Thirty Nine male chronic stroke patients, aged from 50 to 65 years were included in the study. They were randomly assigned into three equal groups: Group "A" was the control group, Group "B" was the study group I and Group "C" was the study group II). Patients in the control group received a selected physical therapy program for upper limb for 60 minutes, patients in group B received Task Oriented Training for upper limb for 30 minutes and the same selected physical Therapy program for upper limb for 30 minutes, while patients in group C received Action Observation Training for upper limb for 30 minutes and the same selected Physical Therapy Program for upper limb for 30 minutes. The intervention was administered three times weekly over a period of four consecutive weeks. Reaching measurements were done using Reaching Performance Scale for stroke (RPSS) and WolF Motor Function Test (WMFT) pre- and post-treatment.

03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Stroke
  • Action Observation Training
  • Task Oriented Training
  • Reaching Performance Scale for Stroke
  • Wolf Motor Function Test
04

Who can participate

Ages eligible
50 Years to 65 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with Chronic stroke diagnosed and referred by a neurologist.
  • Patient's ages ranged from 50-65 years old, Duration of stroke was between six to 12 months, Spasticity grade of the upper limb was from 1 to 1+ according to the modified Ashworth scale (MAS).
  • Patients with sufficient cognitive abilities that enabled them to understand and follow instructions (Mini-Mental Scale>24), Fugl-Meyer Assessment scale for upper limb scored between 38 and 63.
  • Patients with normal vision and hearing, Medically stable patients.

Exclusion criteria

Exclusion Criteria:

  • Patients with Upper limb dysfunction due to neurological disorders other than Stroke (e.g, Multiple Sclerosis, Parkinsonism...etc).
  • Patients with Severe sensory deficits in the paretic upper limb, Psychological or severe cognitive disorders, Severe cardiovascular disease that can preclude intervention.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Double (Participant, Investigator)
Enrollment
39 participants (actual)

Study arms

  • Experimental
    Group A

    Other: Selected physical therapy program

  • Experimental
    Group B

    Other: Selected physical therapy program · Other: Task Oriented Training for Upper limb

  • Experimental
    Group C

    Other: Selected physical therapy program · Other: Action Observation Training Program

Interventions

  • OtherSelected physical therapy program

    Passive stretching, active range of motion exercises, isometric strengthening, and functional gripping practice for the hand

  • OtherTask Oriented Training for Upper limb

    Seated in chair with arm and back support, with forearms resting on a table 73 cm high. Functional movements were trained through task-oriented exercises involving simple activities of daily living(ADL), such as eating (using a plate and spoon), personal hygiene (combing hair, brushing teeth), and tasks using household items (e.g., handling a cup and spoon, or opening a bottle and cap). Each task was repeated five times. Patients were allowed rest periods of five minutes as needed during the exercise sessions.

  • OtherAction Observation Training Program

    sat comfortably in a chair or wheelchair with both arms resting on a table (73 cm high) positioned 50 cm from a 15.6-inch colored laptop screen. They were instructed to attentively observe action videos displayed on the screen and then imitate the observed movements using their affected upper limb. A total of 30 action videos were used, each lasting approximately 50 seconds and demonstrating specific upper limb movements, such as wrist flexion/extension, abduction/adduction, pronation/supination, ulnar/radial deviation, and various grasping and manipulation tasks (e.g., handling coins, pens, a computer mouse, jar lids, bottle caps, typewriting, dialing a phone, and feeding).

06

What researchers measure

Primary outcomes

  1. Reaching Performance Scale for Stroke (RPSS)

    Evaluates the performance of two reaching and grasping tasks

    Time frame: 4 Weeks

  2. Wolf Motor Function Test (WMFT)

    Designed to assess upper limb motor function following stroke or traumatic brain injury

    Time frame: 4 Weeks

07

Study locations

1 site
  • Al Ryada University for Science and Technology
    Sadat, Menoufia 32897, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2025 to primary completion in Jul 2025, 1 month.

Of 3,108 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 1 month is below that.

Counting every sponsor, half of 3,252 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 20, 2025
First posted
Aug 27, 2025
StartActual
Jun 2, 2025
Primary completionActual
Jul 25, 2025
CompletionActual
Aug 5, 2025
Last update
Aug 27, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 27, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07143500
Lead sponsor
Ahmed Alshimy
Responsible party
Ahmed Alshimy (Lecturer of Physical Therapy for Neurology and it's Surgery, AlRyada University for Science & Technology) — Sponsor-investigator
First posted
Aug 27, 2025
Start date
Jun 2, 2025
Primary completion
Jul 25, 2025
Completion
Aug 5, 2025
Last update
Aug 27, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion